Strategic Partnerships Sakura Finetek Europe's recent collaborations with Hamamatsu Corporation and NexInfo Solutions highlight opportunities to promote integrated imaging and enterprise resource planning solutions that enhance workflow efficiency and digital imaging quality for pathology labs.
Innovative Product Launches The launch of advanced solutions like the Tissue-Tek xPrint LP Laser Cassette Printer and Tissue-Tek Genie staining system presents opportunities to upsell complementary lab automation and digital pathology technologies to labs seeking to modernize and streamline tissue processing workflows.
Market Expansion With a focus on automating anatomic pathology and a customer base expanding through innovative product offerings and strategic alliances, there is significant potential to target healthcare providers and pathology labs aiming to enhance diagnostic precision and operational efficiency.
Digital Transformation Focus Sakura’s emphasis on scan-ready slides, digital imaging, and cloud-based enterprise solutions indicates a strong alignment with labs investing in digital transformation, opening doors for sales of digital pathology infrastructure and managed cloud services.
Leadership Growth The recent appointment of a new President and General Manager demonstrates a potential for increased strategic initiatives and expanded outreach, creating opportunities to engage senior decision-makers with tailored solutions in pathology automation and digital solutions.
$1B$10B
$1B$10B
$10B
$250M$500M
$10B
$10B
$1B$10B
$10B
$1B$10BSakura Finetek Europe uses 8 technology products and services including Crazy Egg, ISO 9001, Open Graph, and more. Explore Sakura Finetek Europe's tech stack below.
| Sakura Finetek Europe Email Formats | Percentage |
| F.Last@sakura.eu | 93% |
| First.Last@sakura.eu | 3% |
| Last@sakura.eu | 3% |
| FLast@sakura.eu | 1% |
| FLast@sakuraus.com | 79% |
| First.Last@sakuraus.com | 18% |
| FMiddleLast@sakuraus.com | 2% |
| F.Last@sakuraus.com | 1% |
Medical Equipment ManufacturingSouth Holland, Netherlands201-500 Employees
Empowering pathologists and lab technicians worldwide. When it comes to diagnosing cancer, there’s no time to wait. At Sakura we’re driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. Our Mission: Advancing cancer diagnoses by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care.
Company Overview
Media & News
Funding & FinancialsSakura Finetek Europe's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsSakura Finetek Europe's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com